Bank of Montreal
LSB

Bank of Montreal’s LakeShore Biopharma LSB Stock Holding History

Bank of Montreal’s Portfolio LSB Stock Details LSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,381
Closed -$75.5K – 3994
2024
Q3 		$75.5K Sell
9,381
-19,889
-68% -$103K ﹤0.01% 3322
2024
Q2 		$296K Sell
29,270
-5,142
-15% -$42K ﹤0.01% 2746
2024
Q1 		$275K Buy
+34,412
New +$175K ﹤0.01% 2843

Other funds holding LSB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Montreal's LSB Position: Q4 2024 in Review

Bank of Montreal sold out of LakeShore Biopharma (LSB) in Q4 2024, closing a stake of 9,381 shares — an estimated $75.5K sold.

Bank of Montreal first reported a position in LSB in Q1 2024 and held it in 3 quarters. The position peaked at $296K in Q2 2024. 6 funds tracked by Wall St. Rank hold LSB as of Q4 2024.

  • Bank of Montreal reported no remaining LakeShore Biopharma position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 9,381 LakeShore Biopharma shares in Q4 2024, an estimated $75.5K.
  • Bank of Montreal first reported a position in LakeShore Biopharma in Q1 2024 and held it in 3 quarters.
  • Bank of Montreal's LakeShore Biopharma position peaked at $296K in Q2 2024.
  • 6 funds tracked by Wall St. Rank held LakeShore Biopharma as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.